Non-chicken egg flu vaccine gets European go-ahead
June 21, 2007Manufacturing and Production
Optaflu has gained European approval for use against seasonal influenza. The Novartis drug is the first flu vaccine which does …
GSK commits milions of pounds to new imaging centre
June 21, 2007Research and Development
The largest new imaging centre in Europe – an £83 million collaboration between GlaxoSmithKline (GSK), Imperial College London and the …
GSK highlights new oncology drugs
June 20, 2007Research and Development
GlaxoSmithKline has provided investors with details of a number of new oncology drugs it aims to launch over the next …
Super-rep: working with the new NHS
June 20, 2007Sales and Marketing NHS, sales, strategy
Every year could be called a watershed year for the NHS – it seems that constant change and reinvention is …
Latest news from Datamonitor
June 19, 2007Sales and Marketing
Lilly launches research effort to fight TBEli Lilly has announced the creation of a public-private partnership to conduct early-phase discovery …
NICE set to block blindness drugs
June 15, 2007Sales and Marketing AMD, Lucentis, Macugen, NICE
Most patients in England and Wales will be denied access to drugs for the leading cause of sight loss if …
Generic firm Dr Reddy’s opens its first European R&D base
June 15, 2007Sales and Marketing
Dr Reddy's Laboratories plans to become an R&D-based company are picking up pace with the opening of its first European …
Independent NHS idea won’t work, says Hewitt
June 15, 2007NHS
Patricia Hewitt has dismissed the idea of making the NHS fully independent from politicians, first proposed by Gordon Brown a …
FDA committee scotches Acomplia’s prospects
June 15, 2007Sales and Marketing
The future of Sanofi-Aventis' potential blockbuster Acomplia has been dealt a serious blow after an influential committee of FDA advisers …
Moore’s Sicko stirs controversy
June 13, 2007Sales and Marketing
Michael Moore's latest film opens at cinemas this month and has predictably raised passions with its critical dissection of the …
Avandia scare casts doubt over its future for Alzheimer’s
June 13, 2007Sales and Marketing Avandia, diabetes, safety
New safety warnings about cardiovascular side-effects seen in patients taking Avandia have cast a shadow over the drug’s future as …
ProStrakan begins pan-European launch campaign with Tostran
June 11, 2007Sales and Marketing
ProStrakan has unveiled Tostran in the UK, the first in a pan-European programme of product launches.Tostran is a testosterone replacement …
Latest news from Datamonitor
June 8, 2007Research and Development, Sales and Marketing
Accorda enrols first patient in phase III MS studyAcorda Therapeutics has begun a second phase III clinical study of Fampridine-SR …
Scientists hail new gene discovery a landmark
June 7, 2007Research and Development
DNA samples from 17,000 people across the UK have helped a consortium of scientists to pinpoint genes responsible for diseases …
Quintiles invests
June 7, 2007Research and Development
Contract research organisation Quintiles is to spend £7.5 million (€11 million) on a new home for its Scottish product development …
Amgen boosts pipeline with spending spree
June 7, 2007Research and Development, Sales and Marketing
Amgen has spent $720 million acquiring two US biotech companies in deals that add potential treatments for diabetes and kidney …
Sanofi supports Gardasil with disease awareness campaign
June 7, 2007Medical Communications
Sanofi Pasteur MSD has launched an awareness campaign to encourage women to talk about cervical cancer, the human papillomavirus and …
MHRA investigates links in spate of counterfeits
June 6, 2007Manufacturing and Production
Counterfeit versions of a prostate cancer drug have prompted the MHRA to issue its third alert about fake drugs in …
BMS launches next generation arthritis treatment Orencia
June 6, 2007Sales and Marketing
Bristol-Myers Squibb has launched its next generation rheumatoid arthritis treatment Orencia in the UK, offering patients a novel way of …
Bavarian Nordic secures $1.6 billion deal with US government
June 6, 2007Sales and Marketing
Danish company Bavarian Nordic has secured a massive new contract to provide the US with millions of doses of smallpox …
Latest content
Long-acting therapies set to reshape HIV treatment market
MHRA approves Romvimza for tenosynovial giant cell tumour
